|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
Eidos Therapeutics, Inc. (EIDX) |
|
|
$122.21 0.00 (0.00%) as of 4:30 Mon 1/25
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
38,660,000 |
Market
Cap: |
4.72(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$122.21 - $122.21 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-06-27 |
2024-03-26 |
2023-09-26 |
2022-09-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Fox Jonathan C |
See Remarks |
|
2019-11-26 |
4 |
GD |
$0.00 |
$0 |
I/I |
1,000 |
450,527 |
|
- |
|
Fox Jonathan C |
See Remarks |
|
2019-11-25 |
4 |
S |
$56.52 |
$565,218 |
I/I |
(10,000) |
451,527 |
|
- |
|
Siu Christine |
CFO and Secretary |
|
2019-11-22 |
4 |
S |
$54.71 |
$547,456 |
D/D |
(10,000) |
36,470 |
|
- |
|
Siu Christine |
CFO and Secretary |
|
2019-11-22 |
4 |
OE |
$0.59 |
$5,900 |
D/D |
10,000 |
46,470 |
|
- |
|
Siu Christine |
CFO and Secretary |
|
2019-11-21 |
4 |
S |
$55.12 |
$1,378,077 |
D/D |
(25,000) |
36,470 |
|
- |
|
Siu Christine |
CFO and Secretary |
|
2019-11-21 |
4 |
OE |
$0.59 |
$14,750 |
D/D |
25,000 |
61,470 |
|
- |
|
Fox Jonathan C |
See Remarks |
|
2019-11-21 |
4 |
S |
$55.11 |
$551,073 |
I/I |
(10,000) |
461,527 |
|
- |
|
Turtle Cameron |
Chief Business Officer |
|
2019-11-20 |
4 |
S |
$55.54 |
$557,502 |
D/D |
(10,000) |
85,155 |
|
- |
|
Fox Jonathan C |
See Remarks |
|
2019-11-18 |
4 |
AS |
$50.26 |
$502,574 |
I/I |
(10,000) |
471,527 |
|
- |
|
Fox Jonathan C |
See Remarks |
|
2019-11-15 |
4 |
AS |
$44.88 |
$227,129 |
I/I |
(5,000) |
481,527 |
|
- |
|
Fox Jonathan C |
See Remarks |
|
2019-10-15 |
4 |
AS |
$36.16 |
$180,818 |
I/I |
(5,000) |
486,527 |
|
- |
|
Sinha Uma |
Chief Scientific Officer |
|
2019-09-25 |
4 |
S |
$38.38 |
$96,016 |
D/D |
(2,500) |
343,581 |
|
- |
|
Fox Jonathan C |
See Remarks |
|
2019-09-16 |
4 |
AS |
$45.74 |
$228,722 |
I/I |
(5,000) |
491,527 |
|
- |
|
Turtle Cameron |
Chief Business Officer |
|
2019-09-04 |
4 |
S |
$41.51 |
$207,923 |
D/D |
(5,000) |
95,155 |
|
- |
|
Fox Jonathan C |
See Remarks |
|
2019-08-15 |
4 |
AS |
$38.36 |
$193,596 |
I/I |
(5,000) |
496,527 |
|
- |
|
Sinha Uma |
Chief Scientific Officer |
|
2019-07-25 |
4 |
S |
$35.65 |
$180,627 |
D/D |
(5,000) |
346,081 |
|
- |
|
Fox Jonathan C |
See Remarks |
|
2019-07-15 |
4 |
S |
$40.04 |
$600,561 |
I/I |
(15,000) |
501,527 |
|
- |
|
Siu Christine |
CFO and Secretary |
|
2019-07-10 |
4 |
S |
$39.37 |
$196,850 |
D/D |
(5,000) |
36,470 |
|
- |
|
Siu Christine |
CFO and Secretary |
|
2019-07-10 |
4 |
OE |
$0.59 |
$2,950 |
D/D |
5,000 |
41,470 |
|
- |
|
Kumar Neil |
Chief Executive Officer |
|
2019-07-03 |
4 |
B |
$29.90 |
$26,382,796 |
I/I |
882,353 |
24,575,501 |
2.64 |
- |
|
Aguiar Eric |
Director |
|
2019-07-03 |
4 |
B |
$29.90 |
$26,382,796 |
I/I |
882,353 |
24,575,501 |
2.25 |
- |
|
Satvat Ali J. |
Director |
|
2019-07-03 |
4 |
B |
$29.90 |
$26,382,796 |
I/I |
882,353 |
24,575,501 |
2.25 |
- |
|
Bridgebio Pharma Llc |
10% Owner |
|
2019-07-03 |
4 |
B |
$29.90 |
$26,382,796 |
I/I |
882,353 |
24,575,501 |
1.5 |
- |
|
Siu Christine |
CFO and Secretary |
|
2019-06-26 |
4 |
OE |
$0.59 |
$10,030 |
D/D |
17,000 |
36,470 |
|
- |
|
Siu Christine |
CFO and Secretary |
|
2019-06-05 |
4 |
S |
$29.34 |
$509,487 |
D/D |
(17,000) |
19,470 |
|
- |
|
141 Records found
|
|
Page 4 of 6 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|